tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP

Crispr Therapeutics AG (CRSP) Ownership - Who Owns Crispr Therapeutics AG?

7,624 Followers

Crispr Therapeutics AG (CRSP) Ownership Overview

23.58%17.06%34.84%24.52%
23.58% Insiders
34.84% Other Institutional Investors
24.52% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 51.90% of the company’s stock is owned by Institutional Investors, 23.58% is owned by Insiders and 24.52% is owned by Public Companies and Individual Investors.
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail and individual investors. Approximately 51.90% of the company’s stock is owned by Institutional Investors, 23.58% is owned by Insiders and 24.52% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 21, 2024
James R. Kasinger
Gc & Secretary
Sold$152409

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$208270
Dec 31, 2023Bought$327147
Dec 31, 2023Sold$3132065
Dec 31, 2023Bought$534360110

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,157,028Institution9.61%434,688,022
7,295,513Institution8.59%388,777,888
3,550,544Institution4.18%189,208,490
1,462,005Institution1.72%77,910,246
1,191,100Institution1.40%63,473,719
1,180,449Institution1.39%62,906,127
1,126,437Institution1.33%60,027,828
1,052,256Institution1.24%56,074,722
935,136Institution1.10%49,833,397
902,543Institution1.06%48,096,516

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,550,544Institution4.18%189,208,490
1,191,100Institution1.40%63,473,719
1,180,449Institution1.39%62,906,127
1,052,256Institution1.24%56,074,722
902,543Institution1.06%48,096,516
870,389Institution1.03%46,383,030
798,425Institution0.94%42,548,068
528,990Institution0.62%28,189,877
455,000Institution0.54%24,246,950
402,458Institution0.47%21,446,987

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,528,957Institution6.51%294,638,119
1,742,077Institution2.05%92,835,283
1,189,400Institution1.40%81,069,504
915,970Institution1.08%50,863,814
572,078Institution0.67%30,486,037
376,783Institution0.44%20,922,760
256,856Institution0.30%17,507,305
226,351Institution0.27%12,569,271
215,545Institution0.25%11,969,214
83,719Institution0.10%4,648,916

FAQ

Who Owns Crispr Therapeutics AG (CRSP)?
According to the latest TipRanks data, approximately 34.84% of the company's stock is held by institutional investors, 23.58% is held by insiders, and 24.52% is held by retail investors.
    What percentage of Crispr Therapeutics AG (CRSP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 34.84% of Crispr Therapeutics AG (CRSP) stock is held by institutional investors.
      What percentage of Crispr Therapeutics AG (CRSP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 24.52% of Crispr Therapeutics AG (CRSP) stock is held by retail investors.
        Who owns the most shares of Crispr Therapeutics AG (CRSP)?
        Cathie Wood owns the most shares of Crispr Therapeutics AG (CRSP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis